Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
$
30.00
Sophie Robert, PharmD - An Open-Label Assessment of Aripiprazole in the Treatment of PTSD quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-42-1-robert
Categories:
Psychopharmacology Bulletin
,
VOL 42 No. 1 Articles
Tags:
aripiprazole
,
helen-g-ulmer
,
mark-b-hamner
,
mary-w-brown
,
medworks-media
,
no-1
,
posttraumatic-stress-disorder
,
psychopharmacology
,
psychopharmacology-bulletin
,
second-generation-antipsychotics
,
sophie-robert
,
treatment
,
valerie-l-durkalski
,
volume-42
Description
Description
Sophie Robert, PharmD
ORIGINAL RESEARCH
An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
Sophie Robert, Mark B. Hamner, Valerie L. Durkalski, Mary W. Brown, Helen G. Ulmer
MWM_PSB-42-01-2009-ROBERT
Share On Facebook
Tweet This Product
Pin This Product
Email This Product
Related products
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Page load link
Go to Top
